Offer of research services of the Jagiellonian Center for Drug Development (JCET)
The Jagiellonian Center for Drug Development (JCET) is a research unit of the Jagiellonian University in Krakow. JCET was created to conduct innovative interdisciplinary research on the mechanisms of endothelial and vascular wall pharmacotherapy, as well as to develop new drugs aimed at endothelium and to build cooperation with industry in this field. JCET laboratories are accredited in the Good Laboratory Practice (GLP) standard and are located in the modern Life Science Park in Krakow.
The Jagiellonian Center for Drug Development (JCET) offers comprehensive research services for the pharmaceutical and related industries. JCET services concern, among others assessment of the safety of drugs and dietary supplements in models vitro and in animal studies, as well as analyzes of the efficacy of substances in selected disease models in vivo (e.g. hypertension, atherosclerosis, diabetes). The scope of potential cooperation includes conducting scientific consultations, providing advanced research equipment, carrying out commissioned research, as well as participation in joint research and implementation projects. The JCET offer also includes access to the wide research potential of JCET partners in Poland and abroad.
Meet the presenter: